Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Chimeric momp antigen, method and use

A compound and composition technology, applied in the direction of chlamydia antigen components, chemical instruments and methods, antibacterial drugs, etc., can solve problems such as inability to provide effects and lack of functionality, achieve flexible administration routes, improve immune effects, and increase. The effect of great stability

Active Publication Date: 2013-04-24
SPIXIA BIOTECH
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the isolated epitope may not be functional in a synthetic context and thus not provide the desired effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric momp antigen, method and use
  • Chimeric momp antigen, method and use
  • Chimeric momp antigen, method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0058] In order for those skilled in the art to be able to implement the present invention, several embodiments of the present invention will be described in more detail below with reference to the accompanying drawings. However, this invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The examples do not limit the invention, but the invention is only limited by the appended claims. Furthermore, the terminology used in the detailed description of the specific embodiments shown in the drawings is not intended to be limiting of the invention.

[0059] The following description focuses on an embodiment of the invention applicable to a polypeptide for generating a protective immune response against Chlamydia trachomatis, and in particular...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention regards polypeptides capable of eliciting an immunological response that is protective against Chlamydia trachomatis. The polypeptide comprises a first amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 1 and a second amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 2. Furthermore, production of these polypeptides and pharmaceutical compositions comprising them are also provided.

Description

technical field [0001] The present invention relates generally to the field of polypeptides capable of inducing a protective immune response (reaction) against Chlamydia trachomatis. More specifically, the invention relates to the production of these polypeptides and to pharmaceutical compositions comprising them. Background technique [0002] The major outer membrane protein (MOMP), one of the proteins forming the outer membrane complex of Chlamydia trachomatis, is known to induce two T-cell responses and neutralize antibodies against Chlamydia infection in mammals such as humans. Schematic overview of MOMP proteins in figure 1 Shown in, adapted from Findlay HE, McClafferty H & Ashley RH (2005), Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis major outer membrane protein). BMC Microbiology 5,5 is a paper elucidating the topology of MOMP proteins. exist figure 1 In, A represents the cell membrane and B represents th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/295A61K39/118
CPCC07K14/295C07K2319/40A61K39/118A61P31/04
Inventor S·安德森·斯特里德
Owner SPIXIA BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com